GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Varian Medical Systems Inc (NYSE:VAR) » Definitions » YoY EBITDA Growth

Varian Medical Systems (Varian Medical Systems) YoY EBITDA Growth : 5.66% (As of Dec. 2020)


View and export this data going back to 1976. Start your Free Trial

What is Varian Medical Systems YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Varian Medical Systems's YoY EBITDA Growth for the quarter that ended in Dec. 2020 was 5.66%.

Varian Medical Systems's EBITDA per Share for the three months ended in Dec. 2020 was $1.64.


Varian Medical Systems YoY EBITDA Growth Historical Data

The historical data trend for Varian Medical Systems's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Varian Medical Systems YoY EBITDA Growth Chart

Varian Medical Systems Annual Data
Trend Sep11 Sep12 Sep13 Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20
YoY EBITDA Growth
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.89 -23.17 37.09 -1.04 -9.44

Varian Medical Systems Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -8.37 -38.69 37.18 -10.12 5.66

Varian Medical Systems YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Varian Medical Systems's YoY EBITDA Growth for the fiscal year that ended in Sep. 2020 is calculated as:

YoY EBITDA Growth (A: Sep. 2020 )
=(EBITDA per Share (A: Sep. 2020 )-EBITDA per Share (A: Sep. 2019 ))/ | EBITDA per Share (A: Sep. 2019 ) |
=(5.15-5.687)/ | 5.687 |
=-9.44 %

Varian Medical Systems's YoY EBITDA Growth for the quarter that ended in Dec. 2020 is calculated as:

YoY EBITDA Growth (Q: Dec. 2020 )
=(EBITDA per Share (Q: Dec. 2020 )-EBITDA per Share (Q: Dec. 2019 )) / | EBITDA per Share (Q: Dec. 2019 )) |
=(1.643-1.555)/ | 1.555 |
=5.66 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Varian Medical Systems YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Varian Medical Systems's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Varian Medical Systems (Varian Medical Systems) Business Description

Traded in Other Exchanges
N/A
Address
3100 Hansen Way, Palo Alto, CA, USA, 94304-1038
Varian Medical Systems designs, manufactures, and sells radiation technology for use in two business segments: oncology systems and proton therapy. The Americas account for the largest portion of revenue (47%), followed by Europe, the Middle East, and Africa (33%) and Asia-Pacific (19%).
Executives
Jesse Michael Bruff officer: SVP Finance, CFO 3100 HANSEN WAY, PALO ALTO CA 94304
Magnus Momsen officer: SVP, CAO, Corporate Controller VARIAN MEDICAL SYSTEMS INC. 3100 HANSEN WAY MAIL STOP E327 PALO ALTO CA 94304
Dow R Wilson director, officer: President and CEO VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Kolleen T Kennedy officer: Pres. Proton Solutions, CGO VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Christopher A. Toth officer: SVP and Pres. Oncology Systems 1252 COOLIDGE AVE., SAN JOSE CA 95125
Michael Damon Hutchinson officer: SVP,Chief Legal Officer, Secy 2825 AIRVIEW BLVD, KALAMAZOO MI 49002
Jean Luc Butel director ONE BAXTER PARKWAY, DEERFIELD IL 60015
John W Kuo officer: SVP, Gen Counsel and Secretary VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
Judy Bruner director C/O SANDISK CORPORATION, 601 MCCARTHY BLVD., MILPITAS CA 95035
Beau Michelle Le director 800 N. MICHIGAN AVENUE #3703 CHICAGO IL 60611
Anat Ashkenazi director LILLY CORPORATE CENTER, INDIANAPOLIS IN 46285
Jeffrey R. Balser director 3657 RICHLAND AVE., NASHVILLE TN 37205
Regina E Dugan director VARIAN MEDICAL SYSTEMS INC, 3100 HANSEN WAY MAIL STOP E327, PALO ALTO CA 94304
David J Illingworth director 3100 HANSEN WAY PALO ALTO CA 94304
R Andrew Eckert director THREE RAVINIA DRIVE, ATLANTA GA 30346

Varian Medical Systems (Varian Medical Systems) Headlines

From GuruFocus